Dr. Farmakiotis is the Director of Transplant and Oncology Infectious Diseases (ID) at Rhode Island Hospital, the Lifespan Cancer Center and Cardiovascular Institute (heart transplant and VAD ID clinic). He also attends on the teaching general ID service.
Dr. Farmakiotis graduated valedictorian from the Aristotle University of Thessaloniki, Greece, and trained in Internal Medicine at Albert Einstein College of Medicine/Jacobi Medical Center in the Bronx, NY. He completed his ID fellowship at Baylor College of Medicine on the MD Anderson Immunocompromised Host Track, in Houston, TX, and served as Chief Fellow for Baylor ID, followed by one year of advanced training in Transplant-Oncology ID at Brigham and Women's Hospital and the Dana-Farber Cancer Institute of Harvard Medical School.
Dr. Farmakiotis' clinical and research interests focus on common and opportunistic infections in immunocompromised patients, particularly invasive fungal infections, mechanisms and clinical significance of resistance to antifungals in Candida species, antifungal stewardship, VAD infections, CMV, HIV and hepatitis-C in transplantation, and COVID-19.
| Hawley JE, Sun T, Chism DD, Duma N, Fu JC, Gatson NTN, Mishra S, Nguyen RH, Reid SA, Serrano OK, Singh SRK, Venepalli NK, Bakouny Z, Bashir B, Bilen MA, Caimi PF, Choueiri TK, Dawsey SJ, Fecher LA, Flora DB, Friese CR, Glover MJ, Gonzalez CJ, Goyal S, Halfdanarson TR, Hershman DL, Khan H, Labaki C, Lewis MA, McKay RR, Messing I, Pennell NA, Puc M, Ravindranathan D, Rhodes TD, Rivera AV, Roller J, Schwartz GK, Shah SA, Shaya JA, Streckfuss M, Thompson MA, Wulff-Burchfield EM, Xie Z, Yu PP, Warner JL, Shah DP, French B, Hwang C, COVID-19 and Cancer Consortium (CCC19). "Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States." JAMA Network Open, vol. 5, no. 1, 2022, pp. e2142046. |
| Choueiri, Toni K., Labaki, Chris, Bakouny, Ziad, Hsu, Chih-Yuan, Schmidt, Andrew L., de Lima Lopes, Gilberto, Hwang, Clara, Singh, Sunny R.K., Jani, Chinmay, Weissmann, Lisa B., Griffiths, Elizabeth A., Halabi, Susan, Wu, Ulysses, Berg, Stephanie, O’Connor, Timothy E., Wise-Draper, Trisha M., Panagiotou, Orestis A., Klein, Elizabeth J., Joshi, Monika, Dutra, Miriam Santos, Gatson, Na Tosha N., Blau, Sibel, Singh, Harpreet, Nanchal, Rahul, McKay, Rana R., Nonato, Taylor K., Quinn, Ryann, Rubinstein, Samuel M., Puc, Matthew, Mavromatis, Blanche H., Vikas, Praveen, Faller, Bryan, Zaren, Howard A., Del Prete, Salvatore, Russell, Karen, Reuben, Daniel Y., Accordino, Melissa, Singh, Harpreet, Friese, Christopher R., Mishra, Sanjay, Rivera, Donna R., Shyr, Yu, Farmakiotis, Dimitrios, Warner, Jeremy L. "Breakthrough SARS-CoV-2 Infections Among Patients with Cancer Following Two and Three Doses of COVID-19 mRNA Vaccines." SSRN Electronic Journal, 2022. |
| Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, Awosika J, Bakouny Z, Bashir B, Berg S, Bernardes M, Egan PC, Elkrief A, Feldman LE, Friese CR, Goel S, Gomez CG, Grant KL, Griffiths EA, Gulati S, Gupta S, Hwang C, Jain J, Jani C, Kaltsas A, Kasi A, Khan H, Knox N, Koshkin VS, Kwon DH, Labaki C, Lyman GH, McKay RR, McNair C, Nagaraj G, Nakasone ES, Nguyen R, Nonato TK, Olszewski AJ, Panagiotou OA, Puc M, Razavi P, Robilotti EV, Santos-Dutra M, Schmidt AL, Shah DP, Shah SA, Vieira K, Weissmann LB, Wise-Draper TM, Wu U, Wu JT, Choueiri TK, Mishra S, Warner JL, French B, Farmakiotis D. "Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study." Open Forum Infectious Diseases, vol. 9, no. 3, 2022, pp. ofac037. |
| Farmakiotis D. "COVID-19 Treatments for Nonhospitalized Patients." JAMA, vol. 327, no. 22, 2022, pp. 2247. |
| O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM, COVID-19 Phase 3 Prevention Trial Team. "Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial." JAMA, vol. 327, no. 5, 2022, pp. 432-441. |
| Mecadon K, Hardesty A, Vieira K, Rogers R, Merhi B, Osband AJ, Bayliss Md G, Gohh R, Morrissey P, Farmakiotis D. "Elevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients." Annals of Pharmacotherapy, vol. 56, no. 11, 2022, pp. 1197-1202. |
| Elkrief A, Hennessy C, Kuderer NM, Rubinstein SM, Wulff-Burchfield E, Rosovsky RP, Vega-Luna K, Thompson MA, Panagiotou OA, Desai A, Rivera DR, Khaki AR, Tachiki L, Lynch RC, Stratton C, Elias R, Batist G, Kasi A, Shah DP, Bakouny Z, Cabal A, Clement J, Crowell J, Dixon B, Friese CR, Fry SL, Grover P, Gulati S, Gupta S, Hwang C, Khan H, Kim SJ, Klein EJ, Labaki C, McKay RR, Nizam A, Pennell NA, Puc M, Schmidt AL, Shahrokni A, Shaya JA, Su CT, Wall S, Williams N, Wise-Draper TM, Mishra S, Grivas P, French B, Warner JL, Wildes TM, COVID-19 and Cancer Consortium. "Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium." The Lancet. Healthy longevity, vol. 3, no. 3, 2022, pp. e143-e152. |
| Vieira K, Klein EJ, Lerner AH, Vieira K, Farmakiotis D. "High case fatality rate among fully vaccinated kidney transplant recipients with breakthrough Covid-19 during the Delta surge. Rapid Fire Oral Abstract at the Annual American Transplant Congress (ATC 2022), 2022." American Journal of Transplantation, vol. 22, no. S3, 2022, pp. 331-606. |
| Fu J, Reid SA, French B, Hennessy C, Hwang C, Gatson NT, Duma N, Mishra S, Nguyen R, Hawley JE, Singh SRK, Chism DD, Venepalli NK, Warner JL, Choueiri TK, Schmidt AL, Fecher LA, Girard JE, Bilen MA, Ravindranathan D, Goyal S, Wise-Draper TM, Park C, Painter CA, McGlown SM, de Lima Lopes G Jr, Serrano OK, Shah DP; COVID-19 and Cancer Consortium (CCC19). "Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer." JAMA Network Open, vol. 5, no. 3, 2022, pp. e224304. |
| Mecadon K, Arvanitis P, Farmakiotis D, Rogers R. "Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression." Clinical Transplantation, vol. 36, no. 8, 2022, pp. e14752. |
| Klein EJ, Hardesty A, Vieira K, Farmakiotis D. "Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities." American Journal of Transplantation, vol. 22, no. 2, 2022, pp. 640-645. |
| Koo S, Bold TD, Cheng MP, Farmakiotis D, Hill JA, Knoll B, Koullias Y, Letourneau AR, Little J, Moulton EA, Weiss ZF, Hammond SP. "A Eulogy for Dr. Francisco Miguel Marty Forero." Transplant Infectious Disease, vol. 23, no. 4, 2021, pp. e13645. |
| Pandita, Aaakriti, Dannheim, Katelyn, Madhuripan, Nikhil, Ehsan, Afshin, Farmakiotis, Dimitrios. "Acute Necrotizing Pneumonia from Herpes Simplex Virus." The American Journal of Medicine, vol. 134, no. 2, 2021, pp. e121-2. |
| Hardesty, Anna, Klein, Elizabeth, Vieira, Kendra, Farmakiotis, Dimitrios. "Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19." Open Forum Infectious Diseases, vol. 8, no. Supplement_1, 2021, pp. S28-S29. |
| Vale CA, Egan PC, Ingham R, Farmakiotis D, Reagan JL. "Antibiotic use during cytarabine consolidation in acute myeloid leukemia." Annals of Hematology, vol. 100, no. 1, 2021, pp. 79-84. |
| Tsikala-Vafea M, Belani N, Vieira K, Khan H, Farmakiotis D. "Antibiotic use is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis." International Journal of Infectious Diseases, vol. 106, 2021, pp. 142-154. |
| Hsu A, Matera R, Vieira K, Reagan JL, Farmakiotis D. "Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 29, no. 2, 2021, pp. 707-712. |
| Schmidt AL, Tucker MD, Bakouny Z, Labaki C, Hsu CY, Shyr Y, Armstrong AJ, Beer TM, Bijjula RR, Bilen MA, Connell CF, Dawsey SJ, Faller B, Gao X, Gartrell BA, Gill D, Gulati S, Halabi S, Hwang C, Joshi M, Khaki AR, Menon H, Morris MJ, Puc M, Russell KB, Shah NJ, Sharifi N, Shaya J, Schweizer MT, Steinharter J, Wulff-Burchfield EM, Xu W, Zhu J, Mishra S, Grivas P, Rini BI, Warner JL, Zhang T, Choueiri TK, Gupta S, McKay RR. "Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19." JAMA Network Open, vol. 4, no. 11, 2021, pp. e2134330. |
| Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. "Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium." Annals of Oncology, vol. 32, no. 6, 2021, pp. 787-800. |
| Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL, COVID-19 and Cancer Consortium. "Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19." JAMA Oncology, vol. 7, no. 8, 2021, pp. 1167-1175. |
| Chetboun M, Raverdy V, Labreuche J, Simonnet A, Wallet F, Caussy C, Antonelli M, Artigas A, Goma G, Meziani F, Helms J, Mylonakis E, Levy MM, Kalligeros M, Latronico N, Piva S, Cerf C, Neuville M, Klouche K, Larcher R, Tamion F, Occhiali E, Snacken M, Preiser JC, Kontar L, Riviere A, Silva S, Sarton B, Krouchi R, Dubar V, Palaiodimos L, Karamanis D, Perche J, L'her E, Busetto L, Dicker D, Lev S, Duhamel A, Jourdain M, Pattou F, "LICORNE Lille Intensive Care COVID-19, Obesity Study Group", the "COVID-19 Toulouse ICU Network", the "Hasharon Hospital-Rabin Medical Center Covid-19, Obesity Study Group", the "ID, ICU Covid-19 Study Group", the "Rouen Covid-19, Obesity Study", the "COVID-O-HCL Consortium", the "MICU Lapeyronie", the "Bronx COVID-19, Obesity Study Group", the "MIR Amiens Covid19", the "Strasbourg NHC", the "Foch COVID-19 Study Group". "BMI and pneumonia outcomes in critically ill COVID-19 patients: an international multicenter study." Obesity, vol. 29, no. 9, 2021, pp. 1477-1486. |
| Friese CR, Choueiri TK, Duma N, Farmakiotis D, Grivas P, Rini BI, Shah DP, Thompson MA, Pergam SA, Mishra S, Warner JL. "Care without a compass: including patients with cancer in COVID-19 studies." Cancer Cell, vol. 39, no. 7, 2021, pp. 895-896. |
| Loggers, Elizabeth Trice, Wulff-Burchfield, Elizabeth Marie, Subbiah, Ishwaria Mohan, Khaki, Ali Raza, Egan, Pamela, Farmakiotis, Dimitrios, Phull, Hardeep, Nakasone, Elizabeth, Labaki, Chris, Yu, Peter Paul, Joshi, Monika, Griffiths, Elizabeth A., Wise-Draper, Trisha Michel, Jani, Chinmay, Thakkar, Astha, Puc, Matthew, Hwang, Clara, Mavromatis, Blanche H., Shah, Dimpy P, Warner, Jeremy Lyle. "Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis." Journal of Clinical Oncology, vol. 39, no. 15_suppl, 2021, pp. 12035-12035. |
| Lerner AH, Klein EJ, Hardesty A, Panagiotou OA, Misquith C, Farmakiotis D. "Comparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review." Systematic reviews, vol. 10, no. 1, 2021, pp. 299. |
| Enriquez, Kyle T., Satyanarayana, Gowri, Abidi, Maheen, Advani, Shailesh M, Egan, Pamela, Elkrief, Arielle, French, Benjamin, Friese, Christopher Ryan, Hwang, Clara, Khan, Hina, Lyman, Gary H., McKay, Rana R., Nagaraj, Gayathri, Puc, Matthew, Robilotti, Elizabeth M, Gupta, Shilpa, Shah, Dimpy P, Wise-Draper, Trisha Michel, Yu, Peter Paul, Farmakiotis, Dimitrios. "Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study." Journal of Clinical Oncology, vol. 39, no. 15_suppl, 2021, pp. 6561-6561. |
| Hardesty A, Pandita A, Vieira K, Rogers R, Merhi B, Osband AJ, Aridi J, Shi Y, Bayliss G, Cosgrove C, Gohh R, Morrissey P, Beckwith CG, Farmakiotis D. "Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study." Transplantation Proceedings, vol. 53, no. 4, 2021, pp. 1187-1193. |
| Farmakiotis, Dimitrios, Lerner, Alexis H, Klein, Elizabeth J, Panagiotou, Orestis A, Misquith, Chelsea. "COVID-19 Organ Transplant Rapid Systematic Review." Open Science Framework, 2021. |
| Schmidt AL, Labaki C, Hsu CY, Bakouny Z, Balanchivadze N, Berg SA, Blau S, Daher A, El Zarif T, Friese CR, Griffiths EA, Hawley JE, Hayes-Lattin B, Karivedu V, Latif T, Mavromatis BH, McKay RR, Nagaraj G, Nguyen RH, Panagiotou OA, Portuguese AJ, Puc M, Dutra MS, Schroeder BA, Thakkar A, Wulff-Burchfield EM, Mishra S, Farmakiotis D, Shyr Y, Warner JL, Choueiri TK, COVID-19 and Cancer Consortium. "COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer." Annals of Oncology, vol. 33, no. 3, 2021, pp. 340-346. |
| Masur, Samuel H., Hayward, Anthony, Sanders, Cody, Farmakiotis, Dimitrios. "Karius-ity and the Cat: Diagnosing Hepatosplenic Bartonella Using Next Generation DNA Sequencing and Imaging." Section on Advances in Therapeutics and Technology Program, 2021. |
| Shi Y, Lerner AH, Rogers R, Vieira K, Merhi B, Mecadon K, Osband AJ, Bayliss G, Gohh R, Morrissey P, Farmakiotis D. "Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients." Progress in Transplantation, vol. 31, no. 4, 2021, pp. 368-376. |
| Shah, Dimpy P, Shah, Pankil, Schmidt, Andrew Lachlan, Bakouny, Ziad, Farmakiotis, Dimitrios, Abidi, Maheen, Rubinstein, Samuel M., Figueroa, Cesar J., Labaki, Chris, Friese, Christopher Ryan, Rathmann, Joerg, Hwang, Clara, McKay, Rana R., Park, Cathleen, Puc, Matthew, Nagaraj, Gayathri, French, Benjamin, Warner, Jeremy Lyle, Shete, Sanjay. "Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study." Journal of Clinical Oncology, vol. 39, no. 15_suppl, 2021, pp. 6563-6563. |
| Pandita A, Gillani FS, Shi Y, Hardesty A, McCarthy M, Aridi J, Farmakiotis D, Chiang SS, Beckwith CG. "Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island." PLOS ONE, vol. 16, no. 6, 2021, pp. e0252411. |
| Tsikala-Vafea M, Farmakiotis D. "Response to Letter to the Editor Re 'Antibiotic use is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis'." International Journal of Infectious Diseases, 2021. |
| Vedula, Rahul S., Cheng, Matthew P., Ronayne, Christine E., Farmakiotis, Dimitrios, Ho, Vincent T., Koo, Sophia, Marty, Francisco M., Lindsley, R. Coleman, Bold, Tyler D. "Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease." Blood Advances, vol. 5, no. 1, 2021, pp. 54-60. |
| O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM, Covid-19 Phase 3 Prevention Trial Team. "Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19." New England Journal of Medicine, vol. 385, no. 13, 2021, pp. 1184-1195. |
| Naeem S, Gohh R, Bayliss G, Cosgrove C, Farmakiotis D, Merhi B, Morrissey P, Osband A, Bailey JA, Sweeney J, Rogers R. "Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy." Transplant Infectious Disease, vol. 23, no. 1, 2021, pp. e13451. |
| Li A, Kuderer NM, Hsu CY, Shyr Y, Warner JL, Shah DP, Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP, CCC19 consortium. "The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19." Journal of thrombosis and haemostasis : JTH, vol. 19, no. 10, 2021, pp. 2522-2532. |
| Shi Y, Pandita A, Hardesty A, McCarthy M, Aridi J, Weiss ZF, Beckwith CG, Farmakiotis D. "Validation of pneumonia prognostic scores in a statewide cohort of hospitalized patients with COVID-19." International Journal of Clinical Practice, vol. 75, 2021, pp. e13926. |
| Lerner AH, Shu L, Rogers R, Farmakiotis D. "A kidney transplant recipient with nausea, vomiting, and diarrhea after a recent COVID‐19 exposure." American Journal of Transplantation, vol. 20, no. 9, 2020, pp. 2618-2620. |
| COVID-19 and Cancer Consortium. Electronic address: jeremy.warner@vumc.org., COVID-19 and Cancer Consortium. "A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19:CCC19 Governance, Protocol, and Quality Assurance." Cancer Cell, vol. 38, no. 6, 2020, pp. 761-766. |
| Pandita A, Gil RM, Farmakiotis D. "Call for Action: Racial Disparities in Clinical Research." Clinical Infectious Diseases, 2020. |
| Rogers R, Saharia K, Chandorkar A, Weiss ZF, Vieira K, Koo S, Farmakiotis D. "Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events." BMC Infectious Diseases, vol. 20, no. 1, 2020, pp. 58. |
| Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL, COVID-19 and Cancer Consortium. "Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study." The Lancet, vol. 395, no. 10241, 2020, pp. 1907-1918. |
| Lerner AH, Farmakiotis D. "CMV cell-mediated immunity assays: focus on CD4+ cells." American Journal of Transplantation, vol. 20, no. 8, 2020, pp. 2285-2286. |
| Rogers R, Saharia K, Chandorkar A, Weiss ZF, Vieira K, Koo S, Farmakiotis D. "Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events." BMC infectious diseases, vol. 20, no. 1, 2020, pp. 122. |
| Lerner, Alexis H., Shi, Yiyun, Rogers, Ralph, Farmakiotis, Dimitrios. "Efficacy and safety of half-dose valganciclovir prophylaxis in CMV-seropositive renal transplant recipients." Brown University, 2020. |
| Tsikala-Vafea, Maria, Cao, Weibiao, Olszewski, Adam J., Donahue, John E., Farmakiotis, Dimitrios. "Fatal Mucormycosis and Aspergillosis in an Atypical Host: What Do We Know about Mixed Invasive Mold Infections?." Case Reports in Infectious Diseases, vol. 2020, 2020, pp. 1-6. |
| Higgins AB, Farmakiotis D, Rogers R, Osband AJ, Seo A, Chen B, Birkenbach MP, Crabb D, Xiao L, Leal S, Waites K, Gohh R, Morrissey P, Nau GJ. "Hyperammonemia syndrome due to Ureaplasma urealyticum in a kidney transplant recipient: A case of disseminated disease from a fluoroquinolone-resistant isolate." Transplant Infectious Disease, vol. 22, no. 5, 2020, pp. e13328. |
| Kobayashi, Takaaki, Marra, Alexandre R, Schweizer, Marin L, Ten Eyck, Patrick, Wu, Chaorong, Alzunitan, Mohammed, Salinas, Jorge L, Siegel, Marc, Farmakiotis, Dimitrios, Auwaerter, Paul G, Healy, Heather S, Diekema, Daniel J. "Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis." Open Forum Infectious Diseases, vol. 7, no. 9, 2020, pp. ofaa270. |
| Apostolopoulou A, Esquer Garrigos Z, Vijayvargiya P, Lerner AH, Farmakiotis D. "Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature." Diagnostics, vol. 10, no. 10, 2020, pp. 807. |
| Pelcovits A, Pandita A, Farmakiotis D, Egan P. "Lymphocyte-Depleting Chemotherapy for Aggressive Hematologic Malignancies in Two Patients with Positive SARS-CoV-2 PCR." Leukemia Research, vol. 100, 2020, pp. 106473. |
| Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A, GS-US-540-5773 Investigators. "Remdesivir for 5 or 10 Days in Patients with Severe Covid-19." New England Journal of Medicine, vol. 383, no. 19, 2020, pp. 1827-1837. |
| Kalligeros, Markos, Tashima, Karen T, Mylona, Evangelia K, Rybak, Natasha, Flanigan, Timothy P, Farmakiotis, Dimitrios, Beckwith, Curt G, Sanchez, Martha, Neill, Marguerite, Johnson, Jennie E, Garland, Joseph M, Aung, Su, Byrd, Katrina M, O’Brien, Thomas, Pandita, Aakriti, Aridi, Jad, Macias Gil, Raul, Larkin, Jerome, Shehadeh, Fadi, Mylonakis, Eleftherios. "Remdesivir Use Compared to Supportive Care in Hospitalized Patients with Severe COVID-19: A Single-Center Experience." Open Forum Infectious Diseases, vol. 7, no. 10, 2020, pp. ofaa319. |
| Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani FS, Macias-Gil R, Mileno M, Ramratnam B, Rybak NR, Sanchez M, Tashima K, Mylonakis E, Kantor R. "SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States." Journal of the International AIDS Society, vol. 23, no. 7, 2020, pp. e25573. |
| Farmakiotis, Dimitrios, Weiss, Zoe, Brotherton, Amy L., Morrissey, Paul, Gohh, Reginald, Vieira, Kendra, Taylor, Lynn E., Garland, Joseph M. "Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral Era." Case Reports in Hepatology, vol. 2020, 2020, pp. 1-6. |
| Farmakiotis D. "The Human Microbiome and Checkpoint Inhibition: Potential Benefits From Antibiotic Stewardship." Clinical Infectious Diseases, vol. 71, no. 3, 2020, pp. 701-702. |
| Rivera DR, Peters S, Panagiotou OA, Shah DP, Kuderer NM, Hsu CY, Rubinstein SM, Lee BJ, Choueiri TK, de Lima Lopes G Jr, Grivas P, Painter CA, Rini BI, Thompson MA, Arcobello J, Bakouny Z, Doroshow DB, Egan PC, Farmakiotis D, Fecher LA, Friese CR, Galsky MD, Goel S, Gupta S, Halfdanarson TR, Halmos B, Hawley JE, Khaki AR, Lemmon CA, Mishra S, Olszewski AJ, Pennell NA, Puc MM, Revankar SG, Schapira L, Schmidt A, Schwartz GK, Shah SA, Wu JT, Xie Z, Yeh AC, Zhu H, Shyr Y, Lyman GH, Warner JL, COVID-19 and Cancer Consortium. "Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study." Cancer Discovery, vol. 10, no. 10, 2020, pp. 1514-1527. |
| Alosaimy, Sara, Pearson, Jeffrey, Veve, Michael, Dionne, Brandon, Aleissa, Muneerah, Farmakiotis, Dimitrios, Jorgensen, Sarah C J, Rybak, Michael J. "200. Real-World Experience with Dalbavancin for Complicated Gram-Positive Infections: A Multicenter Evaluation." Open Forum Infectious Diseases, vol. 6, no. Supplement_2, 2019, pp. S118-S119. |
| Cooper R, Dudley J, Farmakiotis D. "A Man With Headache, Fever, and Neck Stiffness." JAMA, vol. 321, no. 16, 2019, pp. 1624-1625. |
| Kyvernitakis A, Pappas O, Farmakiotis D, Horn ET, Benza RL, Bailey SH, Agarwal R. "Bloodstream Infections in Continuous Flow Left Ventricular Assist Device Recipients: Diagnostic and Clinical Implications." ASAIO Journal, vol. 65, no. 8, 2018, pp. 798-805. |
| Kyvernitakis, A., Pappas, O., Farmakiotis, D., Horn, E.T., Benza, R.L., Bailey, S.H., Agarwal, R. "Bloodstream Infections in Left Ventricular Assist Device Recipients Awaiting Transplantation." The Journal of Heart and Lung Transplantation, vol. 37, no. 4, 2018, pp. S135. |
| Serpa JA, Knights S, Farmakiotis D, Campbell J. "Brucellosis in Adults and Children: A 10-Year Case Series at Two Large Academic Hospitals in Houston, Texas." Southern medical journal, vol. 111, no. 6, 2018, pp. 324-327. |
| Lin S, Chen R, Zhu S, Wang H, Wang L, Zou J, Yan J, Zhang X, Farmakiotis D, Tan X, Mylonakis E. "Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes." Mycopathologia, vol. 183, no. 4, 2018, pp. 679-689. |
| Kitmiridou, Despoina, Aung, Su N., Farmakiotis, Dimitrios. "Disseminated Mucormycosis with Positive <i>Aspergillus</i> Galactomannan." Case Reports in Infectious Diseases, vol. 2018, 2018, pp. 4294013. |
| Farmakiotis, Dimitrios, Le, Audrey, Weiss, Zoe, Ismail, Nour, Kubiak, David W., Koo, Sophia. "False Positive Bronchoalveolar Lavage Galactomannan: Effect of host and cut-off value." Mycoses, vol. 62, no. 3, 2018, pp. 204-213. |
| Fung M, Jacobsen E, Freedman A, Prestes D, Farmakiotis D, Gu X, Nguyen PL, Koo S. "Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine." Clinical Infectious Diseases, vol. 68, no. 2, 2018, pp. 247-255. |
| Le A, Farmakiotis D, Reagan JL. "Pruritic Rash in a Patient with Hodgkin's Lymphoma." Cureus, vol. 10, no. 4, 2018, pp. e2450. |
| Weiss Z, Mehta N, Aung SN, Migliori M, Farmakiotis D. "Rapid Reversal of Complete Binocular Blindness With High-Dose Corticosteroids and Lumbar Drain in a Solid Organ Transplant Recipient With Cryptococcal Meningitis and Immune Reconstitution Syndrome: First Case Study and Literature Review." Open Forum Infectious Diseases, vol. 5, no. 2, 2018, pp. ofy007. |
| Kyvernitakis, A., Pappas, O., Wani, A., Farmakiotis, D., Horn, E.T., Murali, S., Benza, R.L., Bailey, S.H., Agarwal, R. "Bloodstream Infections in Continuous Flow Left Ventricular Assist Device Recipients: The Utility of Systemic Inflammatory Response Syndrome for Diagnosing Sepsis and Prediction of Mortality." The Journal of Heart and Lung Transplantation, vol. 36, no. 4, 2017, pp. S259-S260. |
| Koshy, Seena, Ismail, Nour, Astudillo, Carmen Leon, Haeger, Christina Mallarino, Aloum, Obadah, Acharige, Mahesh Thalavitiya, Farmakiotis, Dimitrios, Baden, Lindsey R, Marty, Francisco M, Kontoyiannis, Dimitrios P, Fredenburgh, Laxura, Koo, Sophia. "Breath-Based Diagnosis of Invasive Mucormycosis (IM)." Open Forum Infectious Diseases, vol. 4, no. suppl_1, 2017, pp. S53-S54. |
| Le, Audrey, Chung, Maggie, Pisharodi, Latha, Reagan, John L, Farmakiotis, Dimitrios. "Dysuria in a Patient With AIDS and Lymphoma." Clinical Infectious Diseases, vol. 65, no. 5, 2017, pp. 868-869. |
| Farmakiotis D, Kontoyiannis DP. "Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management." International journal of antimicrobial agents, vol. 50, no. 3, 2017, pp. 318-324. |
| Le A, Farmakiotis D, Tarrand JJ, Kontoyiannis DP. "Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?." Antimicrobial Agents and Chemotherapy, vol. 61, no. 8, 2017. |
| Stone JA, Knoll BM, Farmakiotis D. "Relapsing EBV encephalitis in a renal transplant recipient." IDCases, vol. 10, 2017, pp. 83-87. |
| Black RC Jr, Reagan J, Taliano R, Farmakiotis D. "Rhomboid glossitis in disseminated CMV infection." IDCases, vol. 8, 2017, pp. 42-44. |
| Farmakiotis D, Liakos A, Miller MB, Krane JF, Baden LR, Hammond SP. "An Avid Imitator." Journal of clinical medicine research, vol. 8, no. 3, 2016, pp. 257-9. |
| Tan X, Chen R, Zhu S, Wang H, Yan D, Zhang X, Farmakiotis D, Mylonakis E. "Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model." Antimicrobial Agents and Chemotherapy, vol. 60, no. 6, 2016, pp. 3348-54. |
| Tan X, Zhu S, Yan D, Chen W, Chen R, Zou J, Yan J, Zhang X, Farmakiotis D, Mylonakis E. "Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia." Med Mycol, vol. 54, no. 6, 2016, pp. 557-66. |
| Le, Audrey, Kubiak, David, Koo, Sophia, Farmakiotis, Dimitrios. "Epidemiology of Candidemia in Hospitalized Patients With Acute Leukemia in the Absence of Routine Antifungal Prophylaxis." Open Forum Infectious Diseases, vol. 3, no. suppl_1, 2016. |
| Farmakiotis D, Zeluff B. "IMAGES IN CLINICAL MEDICINE. Metronidazole-Associated Encephalopathy." New England Journal of Medicine, vol. 374, no. 15, 2016, pp. 1465. |
| Farmakiotis D, Kontoyiannis DP. "Mucormycoses." Infectious disease clinics of North America, vol. 30, no. 1, 2016, pp. 143-63. |
| Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, Kontoyiannis DP, Sanglard D, Taj-Aldeen SJ, Alexander BD, Jimenez-Ortigosa C, Shor E, Perlin DS. "Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance." Nature Communications, vol. 7, 2016, pp. 11128. |
| Stempel JM, Farmakiotis D, Tarrand JJ, Kontoyiannis DP. "Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients." Diagnostic microbiology and infectious disease, vol. 85, no. 3, 2016, pp. 391-3. |
| Alevizakos M, Farmakiotis D, Mylonakis E. "Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities." Journal of Thoracic Disease, vol. 8, no. 12, 2016, pp. E1767-E1770. |
| Kubiak DW, Farmakiotis D, Arons V, Hollins RM, Rostas SE, Weiser LM, Baden LR, Marty FM, Koo S. "Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia." Diagnostic microbiology and infectious disease, vol. 84, no. 3, 2016, pp. 223-6. |
| Farmakiotis, Dimitrios, Kubiak, David, Liakos, Alexis, Woolley, Ann E., Issa, Nicolas C., Hammond, Sarah P., Marty, Francisco M., Baden, Lindsey R., Koo, Sophia. "Comparison of Clinical Characteristics and Outcomes Between Candidemic Patients with Positive and Negative β-d-Glucan." Open Forum Infectious Diseases, vol. 2, no. suppl_1, 2015. |
| Calderwood, Michael S., Kubiak, David W., Farmakiotis, Dimitrios, Baden, Lindsey R., Marty, Francisco M. "Decreasing Incidence of Candidemia Without Routine Systemic Antifungal Prophylaxis." Open Forum Infectious Diseases, vol. 2, no. suppl_1, 2015. |
| Farmakiotis D, Kyvernitakis A, Tarrand JJ, Kontoyiannis DP. "Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 21, no. 1, 2015, pp. 79-86. |
| Farmakiotis D, Kontoyiannis DP. "Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients." American Journal of Transplantation, vol. 15, no. 5, 2015, pp. 1141-7. |
| Farmakiotis, Dimitrios, Letourneau, Alyssa R., Galar, Alicia, Koo, Sophia, Maguire, James, Givertz, Michael M., Baden, Lindsey R. "Prolonged Antibiotic Prophylaxis After Left Ventricular-Assist Device (LVAD) Implantation Is Associated With Increased Antibacterial Resistance." Open Forum Infectious Diseases, vol. 2, no. suppl_1, 2015. |
| Woolley, Ann E., Farmakiotis, Dimitrios, Liakos, Alexis, Issa, Nicolas C., Koo, Sophia, Baden, Lindsey R., Marty, Francisco M., Hammond, Sarah P. "Temporal Trends in Stem Cell Transplant and Hematologic Malignancy Patients With Mucormycosis, 2001–2014." Open Forum Infectious Diseases, vol. 2, no. suppl_1, 2015. |
| Wang E, Farmakiotis D, Yang D, McCue DA, Kantarjian HM, Kontoyiannis DP, Mathisen MS. "The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality." Journal of Antimicrobial Chemotherapy, vol. 70, no. 8, 2015, pp. 2362-8. |
| Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP. "Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA." Emerging infectious diseases, vol. 21, no. 11, 2015, pp. 1942-50. |
| Farmakiotis D, Ntouloulis C, Mihailidis N, Theofilogiannakos EK, Makavos G, Bakas A, Vassiliadou E. "Diagnostic value of eosinopenia in non-Typhi Salmonella enteritis." Clinical Infectious Diseases, vol. 59, no. 8, 2014, pp. 1197-8. |
| Shirazi F, Farmakiotis D, Yan Y, Albert N, Do KA, Kontoyiannis DP. "Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis." PLoS ONE, vol. 9, no. 9, 2014, pp. e108635. |
| Farmakiotis D, Tarrand JJ, Kontoyiannis DP. "Drug-resistant Candida glabrata infection in cancer patients." Emerging infectious diseases, vol. 20, no. 11, 2014, pp. 1833-40. |
| Farmakiotis D, Tarrand JJ, Kontoyiannis DP. "Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer." Antimicrobial Agents and Chemotherapy, vol. 58, no. 6, 2014, pp. 3526-9. |
| Farmakiotis D, Shirazi F, Zhao Y, Saad PJ, Albert ND, Roilides E, Walsh TJ, Perlin DS, Kontoyiannis DP. "Methylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies." The Journal of Infectious Diseases, vol. 210, no. 9, 2014, pp. 1471-5. |
| Chien KS, Farmakiotis D, Rodriguez-Barradas MC, Musher DM. "It's not that simple." Clinical Infectious Diseases, vol. 56, no. 2, 2013, pp. 308. |
| Farmakiotis D. "Obesity and serious infections." Annals of Internal Medicine, vol. 159, no. 12, 2013, pp. 859. |
| Farmakiotis D, Chien KS, Shum TC, Rodriguez-Barradas M, Musher DM. "Photo quiz. To scan or not to scan?." Clinical Infectious Diseases, vol. 56, no. 7, 2013, pp. 1003, 1052-3. |
| Farmakiotis D, Ciurea AM, Cahuayme-Zuniga L, Kontoyiannis DP. "The diagnostic yield of skin biopsy in patients with leukemia and suspected infection." The Journal of infection, vol. 67, no. 4, 2013, pp. 265-72. |
| Farmakiotis D, Tverdek FP, Kontoyiannis DP. "The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B." Clinical Infectious Diseases, vol. 56, no. 5, 2013, pp. 701-3. |
| Farmakiotis D, Varughese J, Sue P, Andrews P, Brimmage M, Dobroszycki J, Coyle CM. "Typhoid Fever in an inner city hospital: a 5-year retrospective review." Journal of Travel Medicine, vol. 20, no. 1, 2013, pp. 17-21. |
| Cardenas-Garcia J, Farmakiotis D, Baldovino BP, Kim P. "Wegener's granulomatosis in a middle-aged woman presenting with dyspnea, rash, hemoptysis and recurrent eye complaints: a case report." Journal of medical case reports, vol. 6, 2012, pp. 335. |
| Sanchez JM, Tan JA, Farmakiotis D, Aggarwal V. "Atypical Strokes in a Young African American Male: A Case of Mitochondrial Encephalopathy Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome." Stroke research and treatment, vol. 2011, 2011, pp. 140630. |
| Cabrera VJ, Farmakiotis D, Aggarwal V. "Methylene chloride intoxication treated with hyperbaric oxygen therapy." The American Journal of Medicine, vol. 124, no. 5, 2011, pp. e3-4. |
| Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. "Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis." Human reproduction update, vol. 15, no. 3, 2009, pp. 297-307. |
| Karkanaki A, Piouka A, Katsikis I, Farmakiotis D, Macut D, Panidis D. "Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients." Fertility and Sterility, vol. 92, no. 6, 2009, pp. 2078-81. |
| Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. "Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels." AJP: Endocrinology and Metabolism, vol. 296, no. 2, 2009, pp. E238-43. |
| Pachiadakis I, Chokshi S, Cooksley H, Farmakiotis D, Sarrazin C, Zeuzem S, Michalak TI, Naoumov NV. "Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions." Clinical Immunology, vol. 131, no. 3, 2009, pp. 415-25. |
| Bairactaris C, Demakopoulos N, Tripsianis G, Sioka C, Farmakiotis D, Vadikolias K, Heliopoulos I, Georgoulias P, Tsougos I, Papanastasiou I, Piperidou C. "Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes." Journal of Clinical Neuroscience, vol. 16, no. 2, 2009, pp. 246-52. |
| Topalidou M, Effraimidou S, Farmakiotis D, Papadakis E, Papaioannou G, Korantzis I, Garipidou V. "Low protein Z levels, but not the intron F G79A polymorphism, are associated with unexplained pregnancy loss." Thrombosis research, vol. 124, no. 1, 2009, pp. 24-7. |
| Effraimidou S, Farmakiotis D, Topalidou M. "Protein Z levels and recurrent pregnancy loss." Fertility and Sterility, vol. 91, no. 5, 2009, pp. e27; author reply e28. |
| Tsourdi E, Kourtis A, Farmakiotis D, Katsikis I, Salmas M, Panidis D. "The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia." Fertility and Sterility, vol. 91, no. 4 Suppl, 2009, pp. 1427-30. |
| Delaroudis SP, Efstathiadou ZA, Koukoulis GN, Kita MD, Farmakiotis D, Dara OG, Goulis DG, Makedou A, Makris P, Slavakis A, Avramides AI. "Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly." Clinical endocrinology, vol. 69, no. 2, 2008, pp. 279-84. |
| Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G. "Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels." Fertility and Sterility, vol. 89, no. 4, 2008, pp. 899-906. |
| Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E. "Plasma visfatin levels in normal weight women with polycystic ovary syndrome." European journal of internal medicine, vol. 19, no. 6, 2008, pp. 406-12. |
| Charitidou C, Farmakiotis D, Zournatzi V, Pidonia I, Pegiou T, Karamanis N, Hatzistilianou M, Katsikis I, Panidis D. "The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome." Atherosclerosis, vol. 196, no. 2, 2008, pp. 958-65. |
| Farmakiotis D, Katsikis I, Panidis D. "Calcium homeostasis and anovulatory infertility." Human Reproduction, vol. 22, no. 12, 2007, pp. 3264; author reply 3265. |
| Stogianni A, Nikolopoulos P, Oikonomou I, Gatzola M, Balaris V, Farmakiotis D, Dimitriadis A. "Childhood acute pyelonephritis: comparison of power Doppler sonography and Tc-DMSA scintigraphy." Pediatr Radiol, vol. 37, no. 7, 2007, pp. 685-90. |
| Stylianou C, Galli-Tsinopoulou A, Farmakiotis D, Rousso I, Karamouzis M, Koliakos G, Nousia-Arvanitakis S. "Ghrelin and leptin levels in obese adolescents. Relationship with body fat and insulin resistance." Hormones (Athens, Greece), vol. 6, no. 4, 2007, pp. 295-303. |
| Galli-Tsinopoulou A, Stylianou C, Farmakiotis D, Rousso I, Karamouzis M, Nousia-Arvanitakis S. "Ghrelin serum levels during oral glucose tolerance test in prepubertal obese children with insulin resistance." Journal of pediatric endocrinology & metabolism : JPEM, vol. 20, no. 10, 2007, pp. 1085-92. |
| Farmakiotis D, Farmakis C, Rousso D, Kourtis A, Katsikis I, Panidis D. "The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia." Fertility and Sterility, vol. 88, no. 4, 2007, pp. 847-53. |
| Panidis D, Farmakiotis D. "Treatment of infertility in the polycystic ovary syndrome." New England Journal of Medicine, vol. 356, no. 19, 2007, pp. 1999; author reply 2000-1. |
| Kourtis, Anargyros, Rousso, David, Balaris, Christos, Farmakiotis, Dimitrios, Katsikis, Ilias, Panidis, Dimitrios. "Association of Polycystic Ovary Syndrome and Fibromyalgia in a Patient with Primary Hyperparathyroidism: A Novel Triad? - Reply." Clinical Chemistry, vol. 52, no. 6, 2006, pp. 1209-1210. |
| Katsikis I, Rousso D, Farmakiotis D, Kourtis A, Diamanti-Kandarakis E, Zournatzi-Koiou V, Panidis D. "Creatine phosphokinase in ectopic pregnancy revisited: significant diagnostic value of its MB and MM isoenzyme fractions." American Journal of Obstetrics and Gynecology, vol. 194, no. 1, 2006, pp. 86-91. |
| Galanis N, Farmakiotis D, Kouraki K, Fachadidou A. "Forced expiratory volume in one second and peak expiratory flow rate values in non-professional male tennis players." The Journal of sports medicine and physical fitness, vol. 46, no. 1, 2006, pp. 128-31. |
| Panidis D, Macut D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Spanos N, Petakov M, Bjekic J, Damjanovic S. "Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome." European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 127, no. 1, 2006, pp. 99-105. |
| Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E. "Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome." Fertility and Sterility, vol. 85, no. 6, 2006, pp. 1778-83. |
| Katsikis I, Rousso D, Farmakiotis D, Kourtis A, Diamanti-Kandarakis E, Panidis D. "Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestations." European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 125, no. 2, 2006, pp. 226-32. |
| Panidis D, Farmakiotis D, Koliakos G, Rousso D, Kourtis A, Katsikis I, Asteriadis C, Karayannis V, Diamanti-Kandarakis E. "Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls." Human Reproduction, vol. 20, no. 8, 2005, pp. 2127-32. |
| Panidis D, Farmakiotis D, Rousso D, Koliakos G, Kaltsas T, Krassas G. "Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test." Fertility and Sterility, vol. 83, no. 1, 2005, pp. 232-4. |
| Panidis D, Farmakiotis D, Rousso D, Katsikis I, Kourtis A, Diamanti-Kandarakis E. "Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome." Fertility and Sterility, vol. 84, no. 2, 2005, pp. 538-40. |
| Panidis D, Balaris C, Farmakiotis D, Rousso D, Kourtis A, Balaris V, Katsikis I, Zournatzi V, Diamanti-Kandarakis E. "Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome." Clinical Chemistry, vol. 51, no. 9, 2005, pp. 1691-7. |
| Panidis D, Kourtis A, Kukuvitis A, Farmakiotis D, Xita N, Georgiou I, Tsatsoulis A. "Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione." Human Reproduction, vol. 19, no. 8, 2004, pp. 1728-33. |
| Panidis, D. "Reply: adiponectin levels in women with polycystic ovary syndrome reflect increased adiposity rather than insulin resistance." Human Reproduction, vol. 19, no. 1, 2004, pp. 215-a-216. |
| Panidis D, Farmakiotis D, Kourtis A, Rousso D. "Resistin as a local factor in polycystic ovary syndrome: a novel view of "adipo(cyto)kines"?." Human Reproduction, vol. 19, no. 7, 2004, pp. 1681. |
| Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D. "Serum resistin levels in women with polycystic ovary syndrome." Fertility and Sterility, vol. 81, no. 2, 2004, pp. 361-6. |
| Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D, Koliakos G. "Serum adiponectin levels in women with polycystic ovary syndrome." Human Reproduction, vol. 18, no. 9, 2003, pp. 1790-6. |
| Kintsurashvili E, Duka I, Gavras I, Johns C, Farmakiotis D, Gavras H. "Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells." AJP: Heart and Circulatory Physiology, vol. 281, no. 4, 2001, pp. H1778-83. |
The study of viral, bacterial and fungal infections in immunocompromised individuals, such as those with cancer, hematologic malignancies or solid organ transplant recipients, is challenging. Unfortunately, the relatively new subspecialty of transplant - oncology ID has been historically hampered by empiricism and poorly-supported data from retrospective studies and small case-series. The stakes for the community are high, because of (i) the substantial investments in cancer care, solid organ, or hematopoetic stem cell transplantation and (ii) the significance of appropriate organ allocation and favorable outcomes in transplantation, given the increasing demand with relatively small and stable donor pools.
To this end, I aim to provide critical insight into mechanisms of antibacterial and antifungal resistance, help develop and study new antimicrobial drugs, promote diagnostic stewardship, expand organ donor pools, prepare for future pandemics, and accelerate my career as a leader in the structured study of life-threatening infections in immunocompromised hosts.
Ongoing Research Support:
Brown Physicians Incorporated
COVID-19 treatment modalities among immunosuppressed patients with cancer, and their impact on persistent or relapsing COVID-19.
The goal of this project is to study disparities in the uptake and the efficacy of different treatment modalities against COVID-19 among patients with cancer and also the characteristics of "long-relapsing" COVID-19 among patients with hematologic malignancies.
Role: PI
Merck
Clinical Impact of COVID-19 in Immunocompromised Patients
Comparison of clinical outcomes between immunocompromised and immunocompetent patients with COVID-19
Role: Site PI
Viracor-Eurofins
Using a commercially available assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by intracellular cytokine staining to monitor cellular immunity and predict protection against CMV.
The goal of this investigator-initiated, prospective, blinded study is to assess the performance of a novel, commercially available assay measuring CMV-specific cellular immunity in predicting clinically significant CMV events.
Role: PI
Brown Physicians Incorporated
Brown registry to address unanswered questions in transplant immunology and infectious diseases.
The goal of this registry is to develop a platform for future research projects studying antibacterial resistance in the growing solid organ transplant patient population, as well as develop assays and clinical algorithms to measure the net state of immunosuppression and guide management.
Role: PI
Completed Research Support:
CTI Pharma
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of Pacritinib Plus Standard of Care Versus Placebo and Standard of Care in Hospitalized Patients With Severe COVID-19 With or Without Cancer
The goal of this randomised, double-blided, placebo-controlled clinical trial is to assess the efficacy and tolerability of the selective JAK2 inhibitor in the treatment of patients with severe COVID-19.
Role: Sub-I
Gilead
GS-US-540-5774 A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment.
The goal of this randomised, open-label study is to assess the saftey and tolerability of remdesivir, a new antiviral agent, against SARS-COV2 in patients with moderate disease.
Role: Sub-I
Gilead
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
The goal of this randomised, open-label study is to assess the saftey and tolerability of remdesivir, a new antiviral agent, against SARS-COV2 in patients with severe disease.
Role: Sub-I
ENDEAVOR, Astellas Pharma Global Development
Observational disease registry of patients treated with systemic mold-active triazoles.
The goal of this multi-institutional registry is to capture the baseline characteristics and clinical course of patients treated with the new triazoles voriconazole, posaconazole and isavuconazole.
Role: Site PI
MYCA 12E-01, Astellas Pharma USA Kontoyiannis (PI)
Outcomes of Candida fungemia in adult cancer patients treated with micafungin.
The goal of this project was to study the efficacy and tolerability of monotherapy with micafungin for the treatment of candidemia and deep-seated candidiasis and identify factors associated with clinical failure and death, among patients with cancer, including those with hematologic malignancies and severe neutropenia, an understudied patient population.
Role: Co-PI
Rhode Island Foundation Medical Research Award
Caenorhabditis elegans as a host model to study multi-drug resistance in Candida glabrata..
The goal of this pilot project is to establish the nematode C. elegans as a high throughput, inexpensive model to study MDR in C. glabrata and the efficacy of different antifungal regimens against drug-resistant C. glabrata strains.
Role: PI
INQUIRE, Astellas Pharma Global Development
Non-interventional registry study of systemic antifungal therapy in adult subjects with invasive mucormycosis or invasive aspergillosis caused by a non-fumigatus species.
The goal of this multi-institutional registry is to the clinical course of patients infected with rare molds, specifically Aspergillus non-fumigatus species and the mucorales, with a focus on efficacy and tolerability of isavuconazole.
Role: Site PI
| Year | Degree | Institution |
|---|---|---|
| 2002 | MD | Aristotelian University of Thessloniki |
| Transplant and Oncology Infectious Diseases Fellow | Brigham and Women's Hospital, Transplant Infectious Diseases | 2014-2015 | |
| Research Fellow | MD Anderson Hospital & Tumor Institute of the University of Texas Cancer Center, infectious diseases | 2013-2014 | |
| Clinical Fellow | Baylor College of Medicine, infectious diseases and hiv | 2011-2014 | |
| Clinical Fellow | MD Anderson Hospital & Tumor Institute of the University of Texas Cancer Center, infectious diseases | 2011-2013 | |
| Resident | Albert Einstein College of Medicine, internal medicine | 2008-2011 |
2010, 2011 AECOM Leo M. Davidoff Award for Excellence in the Teaching of Medical Students
2011 2nd place, best clinical research &
1st place, best case presentation at the Jacobi Medical Center annual poster competition
2013 BCM ID Chief Fellow
2014 Permanent US residency as “Scientist of Extraordinary Ability” (EB1)
2nd place, best clinical research at the BCM Annual Medicine Research Symposium
First-author manuscript selected for CDC press coverage
2015 First co-author manuscript selected for CME activity
2016 MMSA Thomas J. Walsh Young Investigator Award
Co-author in manuscript ranked #1 paper in medical mycology at ASM Microbe 2016
Invited speaker for ID Week 2016
Fellow, American College of Physicians (FACP)
Second author manuscript featured in Uptodate
IDSA Mentorship Program
ID Week presentation selected for CME activity
2017 Invited panelist for ID Week 2017
IDSA Mentorship Program
Brown Internal Medicine Residents’ Consultant Teaching Award
First author manuscript fetured in Uptodate
2018 1st place award for best clinical research at the Allegheny annual medicine research retreat
2nd place award at the Pennsylvania Chapter of ACC annual conference
2019 IDSA Maintenance of Certification module development panel
Brown University Institutional Review Board (IRB) Member
2020 Advances in Aspergillosis And Mucormycosis (AAAM) 2020 Outstanding Poster Award
Outstanding Presentation in Clinical Research Award at the annual Warren Alpert Medical School Academic Symposium.
Fellow, Infectious Diseases Society of America (FIDSA)
2021 IDWeek Kass Award (Top Trainee Abstract) and Oral Presentation
| Name | Title |
|---|---|
| Beckwith, Curt | Professor of Medicine |
| Chiang, Silvia | Assistant Professor of Pediatrics |
| Cu-Uvin, Susan | Director of Global Health Initiative, Professor of Health Services, Policy and Practice, Professor of Obstetrics and Gynecology, Professor of Medicine |
| Dannheim, Katelyn | Assistant Professor of Pathology and Laboratory Medicine |
| Egan, Pamela | Assistant Professor of Medicine, Clinician Educator |
| Ehsan, Afshin | Professor of Surgery |
| Flanigan, Timothy | Professor of Medicine, Professor of Health Services, Policy and Practice |
| Garland, Joseph | Associate Professor of Medicine, Clinician Educator |
| Gohh, Reginald | Professor of Medicine |
| Johnson, Jennie | Assistant Professor of Medicine, Clinician Educator |
| Khan, Hina | Assistant Professor of Medicine, Clinician Educator |
| Mileno, Maria | Associate Professor of Medicine |
| Morrissey, Paul | Professor of Surgery |
| Mylonakis, Eleftherios | Charles C.J. Carpenter, MD Professor of Infectious Diseases, Professor of Medicine, Assistant Dean of Medicine, Professor of Molecular Microbiology and Immunology |
| Olszewski, Adam | Associate Professor of Medicine |
| Osband, Adena | Associate Professor of Surgery, Clinician Educator |
| Panagiotou, Orestis | Adjunct Assistant Professor of Epidemiology, Adjunct Assistant Professor of Health Services, Policy and Practice |
| Reagan, John | Associate Professor of Medicine |
| Rogers, Ralph | Assistant Professor of Medicine, Clinician Educator |
| Rybak, Natasha | Assistant Professor of Medicine, Clinician Educator |
| Tashima, Karen | Professor of Medicine |
Rhode Island Hospital
Rhode Island Hospital Cancer Center
Rhode Island Hospital Cardiovascular Institute
The Miriam Hospital
| New York Medical License | State of New York | -2017 | #280093 |
| Uniform Medical License | Rhode Island Board of Medical Licensure & Discipline | -2018 | #MD15134 |
| Hematology-Oncology Infectious Diseases Attending. Rhode Island Hospital, 2015- |
| Transplant-Oncology Infectious Diseases Attending. Rhode Island Hospital, 2015- |
